EMA changes tune, endorses Eisai and Biogen’s Leqembi in restricted Alzheimer’s population aliu Thu, 11/14/2024 – 11:50 More: EMA changes tune, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population Source: fierce
read morePTC wins FDA approval for first brain-delivered gene therapy Kebilidi zbecker Thu, 11/14/2024 – 10:56 More: PTC wins FDA approval for first brain-delivered gene therapy Kebilidi Source: fierce
read moreMerck joins American Lung Association in raising awareness of pulmonary arterial hypertension apark Thu, 11/14/2024 – 10:35 More: Merck joins American Lung Association in raising awareness of pulmonary arterial hypertension Source: fierce
read moreFDA slams Merz over ‘misleading’ Instagram ad for Botox rival ntaylor Thu, 11/14/2024 – 09:57 More: FDA slams Merz over 'misleading' Instagram ad for Botox rival Source: fierce
read more
First participant vaccinated in study of ovx836 booster dose More: Osivax begins phase 2a booster trial for influenza vaccine Source: News
read more
Therapy shows high efficacy in initial trial phase More: AC immune announces positive trial results for early Parkinson’s treatment Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals